JP Morgan Chase’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Other funds holding DALS
JP Morgan Chase's DALS Position: Q2 2023 in Review
JP Morgan Chase sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q2 2023, closing a stake of 250,000 shares — an estimated $2.53M sold.
JP Morgan Chase first reported a position in DALS in Q3 2021 and held it in 7 quarters. The position peaked at $2.94M in Q3 2021. 50 funds tracked by Wall St. Rank hold DALS as of Q2 2023.
- JP Morgan Chase reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q2 2023 after selling out during the quarter.
- JP Morgan Chase sold 250,000 DA32 Life Science Tech Acquisition Corp shares in Q2 2023, an estimated $2.53M.
- JP Morgan Chase first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 7 quarters.
- JP Morgan Chase's DA32 Life Science Tech Acquisition Corp position peaked at $2.94M in Q3 2021.
- 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q2 2023.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.